Similar Articles |
|
Pharmaceutical Executive May 1, 2009 |
Ad(Ventures) in Pharmaland Despite the downside in ad spend, an upside remains in the digital space that's wide open for exploration. |
Pharmaceutical Executive April 1, 2006 Diane West |
Media Spend Trends: Change the Channel Drug marketers still spend lots of money. But they aim at PhRMA loopholes. |
Pharmaceutical Executive May 1, 2007 Diane West |
Spend Trends 2007: Hang 10 Direct-to-Consumer Advertising Hits Its First Decade: Dr. Dot-Com... Digital Detailing... etc. |
Pharmaceutical Executive May 1, 2006 Gary Norman |
Direct to Consumer: Hit 'Em Where It Helps In-Store Pharma Promotions Capture Brand Interest: In-store campaigns are able to extend the reach and value of a pharma ad campaign. They add impressions while communicating more detailed brand messages to target audiences. |
Pharmaceutical Executive July 30, 2007 |
Direct to Consumer: Creativity Through Understanding Creative consumer campaigns begin with a clear understanding of pharma rules and regulations. |
Pharmaceutical Executive June 1, 2006 Philip A. George |
Alternative Media: Online Med Sites Gain Patient Trust Pharma could benefit from a little less TV. |
Pharmaceutical Executive June 1, 2007 Stan Bernard |
Consumerization: Pandora's Pillbox By going direct-to-consumer, the industry unwittingly unleashed a swarm of opportunities for other players to enter the pharmaceutical fray. And they made the most of it. Now, a decade later, pharma is feeling the fallout in consumer trust and product value. It's time to take back control. |
Pharmaceutical Executive September 1, 2010 |
To Brand or Not to Brand? The effectiveness of direct-to-consumer prescription advertising hinges on a consumer's thirst for information. A new study intimates the less info consumers are given up front, the more they seem willing to learn. |
Pharmaceutical Executive October 1, 2010 |
Optimizing TV Advertising Placements & Results Brand managers choosing to advertise an anti-depressant on "Criminal Minds" may not be making the best choice. New methodologies reveal "Law & Order: Special Victims Unit" along with "The Bachelor" to be shows favored by depressives. |
Managed Care March 2005 Martin Sipkoff |
Direct-to-Consumer Ads Garner Mixed Outcomes DTC advertising's reputation as a bully may be largely overstated. There's little evidence that sales of specific drugs increase, and there may be some benefit. |
Pharmaceutical Executive September 1, 2006 Jeannette Park |
Directo to Consumer: No-Name Opportunity Marketers are using unbranded ads to get across the right messages. |
Pharmaceutical Executive August 1, 2008 George Koroneos |
Hard of (Ad)hering Companies have responded to declining profits with a proliferation of patient compliance programs. But where is pharma in this paradigm shift? |
Pharmaceutical Executive May 1, 2006 Stephen Wray |
Alternative Media: Interactive=Integration Interactive technology allows marketers to keep up with the demands of both physicians and consumers. |
Pharmaceutical Executive June 1, 2012 Amy Smith |
Marketing: Medical Devices vs. Pharma Understanding the differences between drug and device marketing can make or break the brand's promotional activities. |
Pharmaceutical Executive January 1, 2007 |
Direct to Consumer: When Television Isn't Enough Pharmaceutical marketers are tightening mass-marketing budgets and putting cash into direct media and integrated programs. |
Pharmaceutical Executive May 1, 2005 Kathy Kastner |
Direct to Consumer: Information vs. Education Although the pharma industry is good at providing information, it has not yet learned how to transform it into reliable education. If pharma marketers can initiate that transformation, they will grab a significant opportunity to connect with consumers. |
Pharmaceutical Executive October 1, 2006 Gary Norman |
Direct to Consumer: If These Walls Had Ears New research shows how DTC affects patients' conversations with physicians. |
BusinessWeek August 15, 2005 Barrett & Weintraub |
Drugmakers Are Changing Channels All those "Ask your doctor if it's right for you" ads on TV haven't delivered. As drugmakers labor to develop more educational and balanced pitches, they're also trying to better target their messages. |
Pharmaceutical Executive July 3, 2007 |
Direct to Consumer: The Secret of My Success Pharmaceutical industry experts sound off on the methods behind an award-winning ad and how the next great direct-to-consumer campaign will come about. |
Pharmaceutical Executive April 1, 2012 Bill Drummy |
Think Digital First While what is considered 'traditional' marketing has evolved over the years, it's clear that a digital strategy is an absolute necessity to compete today; not just tomorrow. |
Pharmaceutical Executive June 1, 2005 Zimmerman & Fay |
Marketing to Professionals: Dr. Ambassador The pharma industry is under siege in the news media. Smart companies must create a role for physicians as ambassadors who can raise patient confidence in drugs and the pharma industry as a whole. |
Pharmaceutical Executive November 1, 2005 Peter H. Nalen |
Alternative Media: Targeting Audiences on the Web The most important web page to communicate with doctors and patients is the page of results that your potential customers see when they use search engines, such as Google, Yahoo!, or MSN. |
Pharmaceutical Executive August 1, 2013 Peter Houston |
The Case for Content Reaching skittish consumers through objective, story driven information is digital marketing's hottest digit. But applying this consumer phenomenon in Big Pharma presents some unique challenges. |
Pharmaceutical Executive December 1, 2005 Patrick Clinton |
PharmExec's 2006 Forecast The 2006 pharmaceutical industry is under assault from Congress, the press and the public, add a complex government program that will unimaginably change industry economics, and subtract revenues from off-patent products. |
Pharmaceutical Executive March 1, 2009 Walker & Stahl |
Activate Your Audience Marketers need to reach beyond disease awareness to spark "movement" communications campaigns. |
Pharmaceutical Executive September 1, 2005 Ray Altieri |
Return on Opportunity Conventions synergize all communications vehicles and create a total impact on the market: advertising, Web presence, programs, detailing, and non-prescription sampling. |
Pharmaceutical Executive December 1, 2005 Meg Columbia-Walsh |
Direct to Consumer: Culturally Relevant Marketing Through culturally relevant marketing, pharma can seamlessly weave its brands into consumers' lives... Also: The 2005 Pharmaceutical Advertising and Marketing Excellence Award recipients... |
BusinessWeek November 4, 2009 Arlene Weintraub |
Ask Your Doctor If This Ad Is Right for You The drug industry is spending billions on TV ads, but they may be scaring consumers away |
Pharmaceutical Executive November 1, 2005 Peter Pitts |
Opinion: It's All Relative PhRMA's new voluntary guidelines are about much more than direct-to-consumer advertising - and they're not really voluntary. |
Pharmaceutical Executive February 1, 2006 Bill Drummy |
The Five "I"s of Internet Marketing A discussion about the fundamentals of pharmaceutical Internet marketing. |
Pharmaceutical Executive September 1, 2011 |
Turning the Ins and Outs of Marketing Inside-Out Keeping your finger on the pulse of consumers leads to better, more actionable insights and better results. |
Managed Care February 2007 MargaretAnn Cross |
How Much Trouble Does Health Care Marketing Cause? Whether for drugs, imaging, surgery, or emergency services, direct-to-consumer advertising sparks lively debate. |
Pharmaceutical Executive May 1, 2005 Ame Wadler |
PR: In the Loop Pharma marketers can help doctors stay abreast of the news. |
InternetNews July 29, 2005 Colin C. Haley |
Pharma Markets Online Curtailing direct-to-consumer drug ads sounds like a bitter pill for creative firms, but the fine print suggests an opening for Internet marketers. |
Pharmaceutical Executive July 1, 2005 Ken Dec |
Direct to Consumer: Moving House The "House of Brands" model is a house of cards. The pharmaceutical industry should change, or risk losing trust forever. |
Pharmaceutical Executive April 1, 2006 David Duplay |
Marketing to Professionals: A Sample Plan Sure, pharmaceutical e-sampling can save money. But there are plenty of other reasons to use it. |
Pharmaceutical Executive July 3, 2007 Jessica DiPaolo |
Toolkit: Good Tailoring Does your marketing campaign reach the huddled masses of frustrated or illiterate healthcare consumers? |
The Motley Fool February 25, 2010 Brian Orelli |
An Untouched Market Waiting to Be Captured Unfilled prescriptions are a potential boon to drug companies. |
Pharmaceutical Executive September 1, 2005 Tenaglia & Angelastro |
No Margin for Error Pharmaceutical companies that will be forced to cut back on sales and marketing spending must focus on value, not volume. Here's how to reduce your spending where it matters the least. |
Pharmaceutical Executive March 1, 2006 Alana Klein |
Direct to Consumer: Q&A with Jill Balderson More Education, Less Promotion. Patient materials should teach rather than tell. |
Pharmaceutical Executive April 10, 2014 |
Obama Policies Reshape Pharma Marketing Health reform initiatives promote transparency, challenge reimbursement, writes Jill Wechsler. |
Search Engine Watch February 20, 2011 Dean Stephens |
Social Networks and Health: Bad Medicine? Social networks can be invaluable for helping consumers with health care decisions, as well as brand awareness for health practitioners, organizations, and treatments -- as long as it's done right. |
BusinessWeek February 9, 2004 John Carey |
Drug Ads Need Stronger Medicine New FDA guidelines may not go far enough in making sure pharmaceutical ads are used appropriately. |
Pharmaceutical Executive May 1, 2005 Jason Hogg |
Marketing to Professionals: Diagnosing MD Behavior A centralized database allows pharma marketers to truly know doctors. |
Pharmaceutical Executive August 1, 2008 |
Harbingers of Change The pharmaceutical industry is changing. Here are eight seminal events that describe how. |
CFO Kris Frieswick |
Clinical Trials A new kind of pricing pressure puts pharmaceutical CFOs in an unfamiliar role: evangelist... |
Pharmaceutical Executive May 1, 2009 Maryann Kuzel |
Weathering the Storm Marketers must stress that maintaining good health behaviors is one of the best things people can do to survive a down market. |
Pharmaceutical Executive December 1, 2005 Grant Winter |
Inside DDMAC: A Conversation with Thomas Abrams Despite heightened scrutiny from industry advocates and the beginnings of self-imposed regulation, pharma companies' violations of DTC regulations have been getting worse, says the director of FDA's Division of Drug Marketing, Advertising, and Communications. |
Pharmaceutical Executive January 1, 2011 |
The Steep, Slow Climb A survey of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade. |
Pharmaceutical Executive March 1, 2009 Brittany Agro |
The New Sales Force The arms race is over, and it's time to reinvent pharma sales. Here's what forward-looking companies are experimenting with, and how it's working. |